SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Goodman who wrote (1059)3/7/2000 3:56:00 AM
From: Jesse Schulman  Read Replies (1) of 1386
 
Aviv hyping P2C3? As of last week he was downplaying, out of concern the hype was out of hand. This is not a rumor.

Anyway, we all know the mortality results aren't significant, from the safety review. Patients died. That's official. It's safe to expect good icp and Glasgow. I have my doubts that analysts and retail buyers will be blown away by indicators they have to look up in books.

One closing note: PARS may or may not cure brain trauma, MS, stroke, hangovers and acne - but it's doing a great job of curing poverty.

Best to all,

itss
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News